Literature DB >> 32716374

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model.

Yiling Yang1, Qianye Chen2, Siru Zhou1, Xinyi Gong1, Hongyuan Xu1, Yueyang Hong1, Qinggang Dai3, Lingyong Jiang4.   

Abstract

Transgenic mouse models are powerful for understanding the critical genes controlling osteoclast differentiation and activity, and for studying mechanisms and pharmaceutical treatments of osteoporosis. Cathepsin K (Ctsk)-Cre mice have been widely used for functional studies of osteoclasts. The signal transducer and activator of transcription 3 (STAT3) is relevant in bone homeostasis, but its role in osteoclasts in vivo remains poorly defined. To provide the in vivo evidence that STAT3 participates in osteoclast differentiation and bone metabolism, we generated an osteoclast-specific Stat3 deletion mouse model (Stat3 fl/fl; Ctsk-Cre) and analyzed its skeletal phenotype. Micro-CT scanning and 3D reconstruction implied increased bone mass in the conditional knockout mice. H&E staining, calcein and alizarin red double staining, and tartrate-resistant acid phosphatase (TRAP) staining were performed to detect bone metabolism. In short, this protocol describes some canonical methods and techniques to analyze skeletal phenotype and to study the critical genes controlling osteoclast activity in vivo.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32716374     DOI: 10.3791/61390

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  2 in total

1.  Napabucasin Induces Mouse Bone Loss by Impairing Bone Formation via STAT3.

Authors:  Xiangru Huang; Anting Jin; Xijun Wang; Xin Gao; Hongyuan Xu; Miri Chung; Qinggang Dai; Yiling Yang; Lingyong Jiang
Journal:  Front Cell Dev Biol       Date:  2021-03-18

Review 2.  Cathepsin K+ Non-Osteoclast Cells in the Skeletal System: Function, Models, Identity, and Therapeutic Implications.

Authors:  Nanyu Zou; Ran Liu; Changjun Li
Journal:  Front Cell Dev Biol       Date:  2022-07-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.